SEC Form 4 · accession 0000899243-16-016830
BIODELIVERY SCIENCES INTERNATIONAL INC · BDSI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas D'Alonzo
Director
Period of report
Mar 29, 2016
Accepted (ET)
Mar 29, 2016 · 6:41 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001103021
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 29, 2016 | M | 30,000 | $2.32 | A | 106,379 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options | $2.32 | Mar 29, 2016 | M | 30,000 | D | Aug 28, 2006 | Aug 28, 2016 | Common Stock | 30,000 | 0 | D |
Explanation of responses
- F1The shares of common stock reported on this Form 4 were acquired by the Reporting Person pursuant to an exercise of options to purchase common stock under the Issuer's Amended and Restated 2001 Incentive Plan.